Evidence map›Paper›PMID 39684409›Full record

ArticleInternational journal of molecular sciences2024

Ubiquitin-Activating Enzyme E1 (UBA1) as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Insights into Immune Infiltration and Functional Implications.

Mingtao Feng, Huanhuan Cui, Sen Li, Liangdong Li, Changshuai Zhou, Lei Chen, Yiqun Cao, Yang Gao, Deheng Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mingtao FengDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Huanhuan CuiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Sen LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Liangdong LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Changshuai ZhouDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Lei ChenDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Yiqun CaoDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Yang GaoDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Deheng LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Funding

National Natural Science Foundation of China No.82103429National Natural Science Foundation of China No.82303311Shanghai Municipal Commission of Science and Technology 22YF1407800
6 · The paper itself

Abstract

Ubiquitin-Activating Enzyme E1 (UBA1), an E1 enzyme involved in the activation of ubiquitin enzymes, has been involved in the onset and progression of different cancers in humans. Nevertheless, the precise contribution of

Indexed as

Biomarkers, TumorBreast NeoplasmsGene Expression Regulation, NeoplasticUbiquitin-Activating EnzymesCell Line, TumorFemaleHumansPrognosisBiomarkers, TumorUBA1 protein, humanUbiquitin-Activating Enzymesbreast cancerimmune infiltratesprognostic biomarkerUBA1

Identifiers

PMID39684409
PMCPMC11641640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.